For US Healthcare Professionals Only

| CTCL Staging Tool

CTCL Staging Tool

Explore the interactive CTCL staging tool that guides you through the clinical staging process for Mycosis Fungoides and Sézary Syndrome.

Mycosis Fungoides and Sézary Syndrome together make up the most common CTCL subtypes and are distinguished from other primary CTCLs by their unique clinical features and histopathology.2

Due to the challenges in the diagnosis and staging of Mycosis Fungoides (MF) and Sézary Syndrome (SS), this website was created to provide insights from disease experts and practical CTCL information and resources.

CTCL Diagnosis

Explore ways to differentiate MF/SS from other common skin diseases (eg, psoriasis, eczema, and atopic dermatitis)

green arrow

TNMB and Staging

Learn how MF/SS can be staged according to 4 disease compartments

green arrow

Hypothetical
Clinical Cases

View a range of possible CTCL presentations

green arrow

Blood Involvement
and Testing

Understand the severity of CTCL in advanced stages and when to test for blood and skin involvement

green arrow

References: 1. Olsen EA, Whittaker S, Willemeze R, et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022;140(5):419-437. 2. Hoppe RT, Kim YH. Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides. UpToDate. Accessed October 24, 2022. https://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides